Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07718971Enrolling By Invitation

UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults

Role: collaborator

NCT03655223Active Not Recruiting

Early Check: Expanded Screening in Newborns

Role: collaborator

NCT05990179Not ApplicableRecruiting

Genomic Uniformed-Screening Against Rare Disease In All Newborns

Role: collaborator

NCT06623435Active Not Recruiting

Real World and Genomic Data Based Asthma Insight Through Network Analysis

Role: collaborator

All 4 trials loaded